These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 17178739)
1. A cryopyrin-associated periodic syndrome with joint destruction. Lequerré T; Vittecoq O; Saugier-Veber P; Goldenberg A; Patoz P; Frébourg T; Le Loët X Rheumatology (Oxford); 2007 Apr; 46(4):709-14. PubMed ID: 17178739 [TBL] [Abstract][Full Text] [Related]
2. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Hawkins PN; Lachmann HJ; Aganna E; McDermott MF Arthritis Rheum; 2004 Feb; 50(2):607-12. PubMed ID: 14872505 [TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic characterization of Italian patients affected by CINCA syndrome. Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754 [TBL] [Abstract][Full Text] [Related]
4. Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS). Ramos E; Aróstegui JI; Campuzano S; Rius J; Bousoño C; Yagüe J Rheumatology (Oxford); 2005 Aug; 44(8):1072-3. PubMed ID: 15840596 [No Abstract] [Full Text] [Related]
5. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Yamazaki T; Masumoto J; Agematsu K; Sawai N; Kobayashi S; Shigemura T; Yasui K; Koike K Arthritis Rheum; 2008 Mar; 58(3):864-8. PubMed ID: 18311804 [TBL] [Abstract][Full Text] [Related]
6. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment. Kuemmerle-Deschner JB; Lohse P; Koetter I; Dannecker GE; Reess F; Ummenhofer K; Koch S; Tzaribachev N; Bialkowski A; Benseler SM Arthritis Res Ther; 2011; 13(6):R196. PubMed ID: 22146561 [TBL] [Abstract][Full Text] [Related]
7. New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes. Maksimovic L; Stirnemann J; Caux F; Ravet N; Rouaghe S; Cuisset L; Letellier E; Grateau G; Morin AS; Fain O Rheumatology (Oxford); 2008 Mar; 47(3):309-10. PubMed ID: 18174231 [TBL] [Abstract][Full Text] [Related]
8. Intrafamilial variable phenotypic expression of a CIAS1 mutation: from Muckle-Wells to chronic infantile neurological cutaneous and articular syndrome. Hentgen V; Despert V; Leprêtre AC; Cuisset L; Chevrant-Breton J; Jégo P; Chalès G; Gall EL; Delpech M; Grateau G J Rheumatol; 2005 Apr; 32(4):747-51. PubMed ID: 15801036 [TBL] [Abstract][Full Text] [Related]
9. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Gattorno M; Tassi S; Carta S; Delfino L; Ferlito F; Pelagatti MA; D'Osualdo A; Buoncompagni A; Alpigiani MG; Alessio M; Martini A; Rubartelli A Arthritis Rheum; 2007 Sep; 56(9):3138-48. PubMed ID: 17763411 [TBL] [Abstract][Full Text] [Related]
10. A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra. Dalgic B; Egritas O; Sari S; Cuisset L Pediatr Nephrol; 2007 Sep; 22(9):1391-4. PubMed ID: 17486372 [TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Aróstegui JI; Aldea A; Modesto C; Rua MJ; Argüelles F; González-Enseñat MA; Ramos E; Rius J; Plaza S; Vives J; Yagüe J Arthritis Rheum; 2004 Dec; 50(12):4045-50. PubMed ID: 15593220 [TBL] [Abstract][Full Text] [Related]
12. A novel missense mutation in CIAS1 encoding the pyrin-like protein, cryopyrin, causes familial cold autoinflammatory syndrome in a family of Ethiopian origin. Shalev SA; Sprecher E; Indelman M; Hujirat Y; Bergman R; Rottem M Int Arch Allergy Immunol; 2007; 143(3):190-3. PubMed ID: 17284928 [TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome. Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428 [TBL] [Abstract][Full Text] [Related]